Background: Direct microscopy and culture tests currently used in the diagnosis of nail mycosis can yield false-negative results, and confirmation of the pathogenic agent, especially in non-dermatophyte infections, is often a lengthy process. Objective: The aim of this study was to investigate the usefulness of the histological examination of nail clipping samples in supplementing the standard microscopic and culture techniques for the diagnosis of onychomycosis. Patients and Methods: One hundred and seventy-two subjects affected by nail alterations suggestive of onychomycosis were evaluated. Nail specimens were studied with 3 different techniques: direct microscopic examination of a 40% KOH clarified preparation, fungal culture and histological examination. Patients positive for fungal infection were re-evaluated with the same techniques after treatment with oral terbinafine, fluconazole or itraconazole and topical application of bifonazole or ciclopirox for 2 months. Results: Direct microscopy was positive in 102 (59.3%) nail specimens. The culture test was positive in 90 cases (52.9%), showing a dermatophyte in 45, a yeast in 23 and a mould in 22 samples. The histological examination was positive in 94 (54.6%) samples. In 4 cases, it was the only investigation confirming the clinical diagnosis of nail mycosis. In most of the cases, the morphological aspect of the hyphae and/or spores suggested also to which group of pathogens (dermatophytes, yeasts or moulds) the mycetes observed in the histological sections could be ascribed. The concurrent presence of a dermatophyte and a mould was evidenced in a few specimens. The control histological examination at the end of the treatment showed negative results or residual non-vital hyphae and/or spores. Conclusions: Results of the present study indicate that the histological examination of nail clipping specimens is a relatively inexpensive, rapid and easily performed procedure. It is useful to confirm or refute the results of routine microscopy and culture tests. Moreover, nail histopathological observation may help in ascribing a pathogenic role of non-dermatophyte isolates and evaluating the effectiveness of antifungal treatment.

Keywords:
Onychomycosis, Nail clipping, Histological examination, Fungal morphology, Diagnosis
1.
Ellis DH, Marley JE, Watson AB, Williams TG: Significance of non-dermatophyte moulds and yeasts in onychomycosis. Dermatology 1997;194(suppl 1):40–42.
2.
Roberts DT: Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. Br J Dermatol 1992;126(suppl 39):23–27.
3.
Williams HC: The epidemiology of onychomycosis in Britain. Br J Dermatol 1993;129:101–109.
4.
Greer DL: Evolving role of non-dermatophytes in onychomycosis. Int J Dermatol 1995;34:521–524.
5.
Ellis DH, Watson AB, Marley JE, Williams TG: Non-dermatophytes in onychomycosis of the toenails. Br J Dermatol 1997;136:490–493.
6.
Haneke E, Roseeuw D: The scope of onychomycosis: Epidemiology and clinical features. Int J Dermatol 1999;38(suppl 2):7–12.
7.
Scher RK, Ackerman AB: Subtle clues to diagnosis from biopsies of nails: The value of nail biopsy for demonstrating fungi not demonstrable by microbiologic techniques. Am J Dermatopathol 1980;2:55–57.
8.
Zaias N: The longitudinal nail biopsy. J Invest Dermatol 1967;49:406–408.
9.
Stone OJ, Barr RJ, Herten RJ: Biopsy of the nail area. Cutis 1978;21:257–260.
10.
Scher RK: Punch biopsies of nails: A simple, valuable procedure. J Dermatol Surg Oncol 1978;4:528–530.
11.
Elewski BE: Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 1996;35(part 2):S6–S9.
12.
Suarez SM, Silvers DN, Scher RK, Pearlstein HH, Auerbach R: Histologic evaluation of nail clippings for diagnosing onychomycosis. Arch Dermatol 1991;127:1517–1519.
13.
Piérard GE, Arrese JE, De Donker P, Piérard-Franchimont C: Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol 1996;34:273–277.
14.
Machler BC, Kirsner RS, Elgart GW: Routine histologic examination for the diagnosis of onychomycosis: An evaluation of sensitivity and specificity. Cutis 1998;61:217–219.
15.
Piérard GE, Arrese JE, Pierre S, Bertrand C, Corcuff P, Leveque JL, Piérard-Franchimont C: Diagnostic microscopique des onychomycoses. Ann Dermatol Vénéréol 1994;121:25–29.
16.
Papini M, Simonetti S, Alberti FP: Indagine micologica in un gruppo di onicodistrofie. Ann It Derm Clin Sper 1985;39:165–175.
17.
Haneke E: Fungal infections of the nail. Semin Dermatol 1991;10:41–53.
18.
Ginter G, Rieger E, Heigl K, Propst E: Increasing frequency of onychomycosis – Is there a change in the spectrum of infectious agents? Mycoses 1996;39(suppl 1):118–122.
19.
Summerbell RC: Epidemiology and ecology of onychomycosis. Dermatology 1997;194(suppl 1):32–36.
20.
Kemna ME, Elewski BE: An US epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996;35:539–542.
21.
Srinivas CR, Ramani A, Kumari TGR, Shivananda PG: Molds in onychomycosis. Int J Dermatol 1993;32:877–878.
22.
McGinnis MR, Hilger AE: Infections caused by black fungi. Arch Dermatol 1987;12:1300–1302.
23.
Mercantini R, Marsella R, Moretto D: Onychomycosis in Rome, Italy. Mycopathologia 1996;136:25–32.
24.
Drake LA, Scher RK, Smith EB, Faich GA, Smith SL, Hong JJ, Stiller MJ: Effect of onychomycosis on quality of life. J Am Acad Dermatol 1998;38:702–704.
25.
Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G: Onychomycosis as a possible origin of disseminated Fusarium spp. infection in a patient with severe aplastic anemia. Clin Infect Dis 1992;14:1167.
26.
Arrese JE, Piérard-Franchimont C, Piérard GE: Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996;18:1296–1298.
27.
Hull PR, Gupta AK, Summerbell RC: Onychomycosis: An evaluation of three sampling methods. J Am Acad Dermatol 1998;39:1015–1017.
28.
English MP: Nails and fungi. Br J Dermatol 1976;94:697–701.
29.
Achten G, Wanet-Rouard J: Onychomycoses in the laboratory. Mykosen 1978;21(suppl 1):125–127.
30.
André J, Achten G: Onychomycosis. Int J Dermatol 1987;26:681–690.
31.
Elewski BE: Bacterial infection in a patient with onychomycosis. J Am Acad Dermatol 1997;37:493–494.
32.
Richardson MD: Effect of Lamisil and azole antifungals in experimental nail infection. Dermatology 1997;194(suppl 1):27–31.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.